Personalized medicine - Part 2: Ethical, legal, and regulatory issues

P and T

Volumn 35, Issue 11, 2010, Pages 624-642

  Vogenberg, F Randy ^a,b,c   Barash, Carol Isaacson ^d   Pursel, Michael ^e  

^a Institute for Integrated Healthcare   (United States)

^b JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d Genetics Ethics and Policy Consulting Inc   (United States)

^e Teva Neuroscience Inc   (United States)

Author keywords

Ethical, legal, and regulatory; GINA; Health plans and coverage; HIPAA privacy rule; HITECH; Protected health information

Indexed keywords

HEALTH CARE SYSTEM; LAW; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL INFORMATION SYSTEM; MEDICINE; PERSONALIZED MEDICINE; REVIEW;

EID: 78649487285     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Agency for Health Care Research and Quality (AHRQ). Reducing and preventing adverse drug events to decrease hospital costs. Research in Action, Issue 1. Rockville, Md. Available at: www.ahrq.gov/qual/aderia/aderia.htm. Accessed May 29, 2010.
2. National Academy of Sciences. A New Biology for the 21st Century. Washington, D.C.: The National Academies Press; 2009. Available at www.nap.edu. Accessed October 4, 2010.
3. Harmon A. New drugs stir debate on rules of clinical trials. The New York Times, September 18, 2010.
4. Institute of Medicine (IOM) of the National Academies, Committee on Health Research and the Privacy of Health Information. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research. Washington, D.C.: National Academy of Science; 2009. Available at: www.iom.edu/Reports/ 2009/Beyond-the-HIPAA-Privacy-Rule-Enhancing-Privacy-Improving-Health-Through- Research.aspx. Accessed May 29, 2010.
5. Borfitz D. Peddicord: New privacy concerns with 'HIPAA 2'. Needham, Mass.: Cambridge Healthtech Insitute; January 4, 2010. Available at: www.bio-itworld.com/2010/1/4/hipaa2.html. Accessed May 31, 2010.
6. Health Information Privacy: HITECH Breach Notification Interim Final Rule. Washington, D.C.: U.S. Department of Health and Human Services. August 2009. Available at: www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/ breachnotificationifr.html. Accessed May 31, 2010.
7. Hartley CP, Jones ED III. HIPAA Plain & Simple: A Health Care Professionals Guide to Achieve HIPAA and HITECH Compliance, updated. American Medical Association; 2010.
8. American Society of Human Genetics. Personalized medicine: Issues affecting adoption of personalized medicine. March 21, 2007. Available at: www.ashg.org/pdf/newsclip/PMC%20-%20Is sues%20affecting%20adoption%20of%20personalized%20medicine.pdf. Accessed May 29, 2010.
9. Genetic Information Nondiscrimination Act (GINA) and per - sonalized medicine: The impact of genetic nondiscrimination legislation on progress in genetics and personalized medicine. Alex andria, Va.: Research! America; 2010. Available at: www.researchamerica.org/gina-issue. Accessed May 30, 2010.
10. Foley & Lardner LLP (newsletter). From speculation to reality: Personalized medicine and the Genetic Information and Non-discrimination Act. Legal News Alert: Life Sciences; November 24, 2009. Available at: www.foley.com/publications/pub-detail.aspx?pubid=6615. Accessed May 31, 2010.
11. Rugnetta M, Kramer W. Paving the Way for Personalized Medicine: Facilitating Inter-Agency Coordination for the Inte gration. Science Progress, September 2009. Available at: www.scienceprogress. org/2009/09/personalized- medicine. Accessed October 19, 2010.